TALZENNA: payments to doctors
Payments that named TALZENNA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $7.4M
- Providers
- 13,209
- Transactions
- 58,146
- Average per transaction
- $127
The per-transaction average — $127 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 13,209 providers the average total is $558, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Pfizer | $7,179,248 | 97.4% |
| Medivation Inc. | $165,196 | 2.2% |
| PBG Puerto RICO LLC | $20,649 | 0.3% |
| Pfizer Chile S.A. | $2,800 | 0.0% |
| Array Biopharma Inc | $2,033 | 0.0% |
| Medivation Services LLC | $353 | 0.0% |
| Pfizer Pharmaceuticals LLC | $124 | 0.0% |